CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
April 2017—Streck’s CE-marked antibiotic resistance monitoring and detection (ARM-D) kits are now available. The Streck ARM-D kits, AmpC and β-lactamase, are multiplex real-time PCR reagents for the detection of more than 450 β-lactamase gene targets.
The ARM-D kits detect the presence of antibiotic-resistance genes in bacteria that cause difficult-to-treat infections and that have the ability to spread quickly, especially in a hospital environment. They can detect the presence of resistance mechanisms of current clinical importance, such as carbapenemases and extended spectrum β-lactamases and some emerging threats, such as the AmpC cephalosporinases. The kits are a genotypic detection method that can be used to identify the most prevalent types of β-lactamase-based antibiotic resistance.
Streck developed the ARM-D kits to provide laboratories with a comprehensive, cost-effective molecular method to detect the most clinically important β-lactamases known to cause therapeutic failure. The kits are for export only, not for sale in the U.S.
Streck, 402-333-1982